Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 108 clinical trials
featured
Advanced Ovarian Cancer

Advanced Ovarian Cancer

  • 116 views
  • 08 Nov, 2020
  • 1 location
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study

To determine the impact of Neoadjuvant chemotherapy on surgical debulking rate, overall and disease-free survival and quality of life (QOL) in patients with advanced EOC.

ovarian epithelial carcinoma
ovarian carcinoma
ovarian cancer
ovarian epithelial cancer
carcinoma
  • 19 views
  • 07 Nov, 2020
  • 1 location
Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer

Aim of the Study is to compare two-years disease-free survival of Cytoreductive Surgery (CRS) and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC, CDDP+Paclitaxel) vs CRS alone in Stage IIIC unresectable epithelial tubal/ovarian cancer with partial or complete response after 3 cycles of 1st line chemotherapy (CBDCA +Paclitaxel).

ovarian epithelial carcinoma
cytoreductive surgery
cancer of the ovary
paclitaxel
cancer chemotherapy
  • 67 views
  • 08 Nov, 2020
  • 2 locations
Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

The aim of this study is to explore the effectiveness and safety of camrelizumab combined with apatinib mesylate in the treatment of relapsed platinum-resistant epithelial ovarian cancer

  • 0 views
  • 25 Jan, 2021
  • 1 location
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

ovarian cancer/fallopian tube/peritoneal cancer were enrolled in this study. The subjects will be randomly assigned to one of the two treatment groups at a 1: 1 ratio, and the stratification factors

  • 0 views
  • 24 Jan, 2021
  • 1 location
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer

epithelial ovarian cancer (EOC), fallopian tube, or primary peritoneal cancer, regardless of platinum sensitivity. Population studied will be female participants experiencing a 1st, 2nd, or 3rd

measurable disease
monoclonal antibodies
metastasis
primary peritoneal carcinoma
peritoneal cancer
  • 113 views
  • 25 Jan, 2021
  • 3 locations
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

TITLE:A Phase II non-comparative study of paclitaxel plus carboplatin in combination with Vorinostat in patients with advanced, recurrent epithelial ovarian cancer. INDICATION:Second-line

neutrophil count
adenocarcinoma
platinum-sensitive ovarian carcinoma
recurrent ovarian cancer
topotecan
  • 10 views
  • 07 Nov, 2020
  • 1 location
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

The prognosis for patients with advanced epithelial ovarian cancer remains poor despite aggressive surgical resection and platinum-based chemotherapy. More than 60% of patients will

recurrent disease
carboplatin/paclitaxel
docetaxel
platinum-based chemotherapy
residual tumor
  • 46 views
  • 07 Nov, 2020
  • 1 location
The IPLA-OVCA Trial Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

Surgery and chemotherapy combined constitute first line treatment in women with advanced ovarian cancer. The aim of surgery apart from staging is cytoreduction, i.e. surgical resection of tumour. Radical resection of all tumour visible by the naked eye followed by adjuvant chemotherapy is associated with best chance of prolonged survival. …

cytoreductive surgery
cancer of the ovary
ovarian cancer stage
metastasis
surgery for ovarian cancer
  • 0 views
  • 30 Jan, 2021
  • 1 location
Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian Fallopian Tube Or Peritoneal Cancer

Pegylated liposomal doxorubicin (PLD; e.g., Doxil®, Lipodox™) will be administered intravenously on Day 1 and EGEN-001 will be administered intraperitoneally on Day 1, 8, 15, and 22 of a 28-day cycle to determine: - The maximum tolerated dose (MTD) and dose limiting toxicities (DLTs) of EGEN-001 when administered in combination …

doxorubicin
intraperitoneal chemotherapy
doxil
peritoneal cancer
  • 227 views
  • 08 Nov, 2020
  • 1 location